MetaVia Stock Forecast
NASDAQ: MTVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:42 AM ET
MTVA analyst consensus
Consensus (2 analysts)
none
Avg. price target
$19.33+1280.71%
- Strong buy 1
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 2 Wall Street analysts covering MetaVia (2026-10-09), 2 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $19.33, with a high estimate of $30.00 and a low estimate of $8.00. The average target implies upside of 1280.7% from the current price of $1.40.
The spread between the highest and lowest targets is 275.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for MTVA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 50% |
| Buy | 1 | 50% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $8.00 | +471.43% |
| Average target | $19.33 | +1280.71% |
| High target | $30.00 | +2042.86% |